Compounds > 5-ethylamino-9-diethylaminobenzo(a)phenothiazinium
Page last updated: 2024-11-07

5-ethylamino-9-diethylaminobenzo(a)phenothiazinium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-ethylamino-9-diethylaminobenzo(a)phenothiazinium: structure in first source; RN refers to the chloride salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131995
MeSH IDM0216840

Synonyms (8)

Synonym
5-ethylamino-9-diethylaminobenzo(a)phenothiazinium chloride
5-ethylamino-9-diethylaminobenzo(a)phenothiazinium
136825-96-2
benzo(a)phenothiazin-7-ium, 9-(diethylamino)-5-(ethylamino)-, chloride
9-(diethylamino)-5-(ethylamino)benzo(a)phenothiazin-7-ium chloride
etnbs
diethyl-[5-(ethylamino)benzo[a]phenothiazin-9-ylidene]azanium;chloride
5-n,9-n,9-n-triethyl-12h-benzo[a]phenothiazin-12-ium-5,9-diamine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (42.86)18.2507
2000's1 (7.14)29.6817
2010's5 (35.71)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
indomethacin
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.. indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.		1.9810aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
nile blue
Nile Blue: RN given refers to chloride; structure. nile blue A : An organic chloride salt having 5-amino-9-(diethylamino)benzo[a]phenoxazin-7-ium as the couterion. fluorescent dye which is also a potent photosensitiser for photodynamic therapy.		2.4320
benzophenothiazine
[no description available]		2.610
carboplatin
[no description available]		2.4920
benzoporphyrin d
benzoporphyrin D: C42H44N4O8, MW 732.821		1.9910
5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium
5- ethylamino-9-diethylaminobenzo(a)phenoselenazinium: structure in first source; RN refers to the chloride salt		2.6930
ConditionIndicatedRelationship StrengthStudiesTrials
Pregnancy
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.		02.610
Bacterial Infections, Gram-Negative
[description not available]		02.110
Bacterial Infections, Gram-Positive
[description not available]		02.110
Gram-Negative Bacterial Infections
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.		02.110
Gram-Positive Bacterial Infections
Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.		02.110
Cancer of Ovary
[description not available]		02.520
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.		02.520
Metastase
[description not available]		02.0610
Benign Neoplasms
[description not available]		02.4220
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.		02.0610
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		02.4220
Anoxemia
[description not available]		02.0710
Hypoxia
Sub-optimal OXYGEN levels in the ambient air of living organisms.		02.0710
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.4120
Granulomas
[description not available]		02.0310
Koch's Disease
[description not available]		02.0310
Granuloma
A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.		02.0310
Tuberculosis
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.		02.0310
EHS Tumor
[description not available]		02.3920
Experimental Mammary Neoplasms
[description not available]		02.3920
Sarcoma, Epithelioid
[description not available]		01.9810
Animal Mammary Carcinoma
[description not available]		01.9810
Sarcoma
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.		01.9810
Carcinoma, Epidermoid
[description not available]		01.9910
Canine Diseases
[description not available]		01.9910
Cancer of Mouth
[description not available]		01.9910
Cancer of Skin
[description not available]		01.9910
Cat Diseases
Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.		01.9910
Facial Neoplasms
New abnormal growth of tissue in the FACE.		01.9910
Mast-Cell Sarcoma
A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.		01.9910
Carcinoma, Squamous Cell
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)		01.9910
Mouth Neoplasms
Tumors or cancer of the MOUTH.		01.9910
Skin Neoplasms
Tumors or cancer of the SKIN.		01.9910
Experimental Neoplasms
[description not available]		0210